New therapy targets breast cancer metastases in brain
When breast cancer spreads to the brain, the prognosis is grim. Patients only have about six months to live.
Aug 26, 2020
0
210
When breast cancer spreads to the brain, the prognosis is grim. Patients only have about six months to live.
Aug 26, 2020
0
210
An international team of researchers reports that modifying an adenovirus a certain way made it an effective tumor killer in mice with retinoblastoma. In their paper published in the journal Science Translational Medicine, ...
Pancreatic cancer is the third leading cause of cancer deaths in the United States, in part because it is very difficult for chemotherapy drugs to reach the pancreas, which is located deep within the abdomen.
Apr 14, 2016
0
309
The prevalence of dental developmental anomalies (DDA) in survivors of childhood cancer differ according to the type of cancer treatment administered, according to researchers at the Hebrew University (HU)-Hadassah School ...
Apr 4, 2022
0
30
A combination of chemotherapy with an immunotherapy meant to unleash the anticancer capacity of the immune system was effective against one of the hardest targets in cancer care, pancreatic cancer, in a national, randomized ...
Jun 4, 2022
0
535
Does fasting help make chemotherapy more effective in breast cancer patients? Researchers led by Leiden University Medical Centre (LUMC) and Breast Cancer Research Group (BOOG) are a step closer to answering that question ...
Jun 25, 2020
0
57
Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent ...
Apr 17, 2019
0
281
Researchers at the São Paulo State Cancer Institute (ICESP) in Brazil have used a genetically manipulated virus to destroy tumor cells upon injection into mice with prostate cancer. The virus also made tumor cells more sensitive ...
Jun 27, 2019
0
7
Researchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination with the drugs nivolumab, and regorafenib.
Targeted radioembolization alongside chemotherapy improved progress-free survival for patients with colon cancer that had metastasized to the liver, according to a study published in the Journal of Clinical Oncology.
Dec 20, 2021
0
33